Related Experiment Videos
Fibrin sealant in breast surgery
1Department of Surgery and School of Medicine, University of Virginia Health Sciences Center, Charlottesville 22906, USA. mmm7k@virginia.edu
Journal of Long-Term Effects of Medical Implants
|December 8, 1997
Summary
Fibrin sealant (FS) can reduce complications after breast cancer surgery. This surgical adhesive improves hemostasis and tissue adherence, decreasing seroma and hematoma formation in axillary lymph-node dissections.
Area of Science:
- Surgical Oncology
- Biomaterials in Medicine
- Breast Cancer Management
Background:
- Axillary lymph-node dissection is crucial for breast cancer staging.
- Common complications include seroma, hematoma, and lymphedema.
- These issues arise from vessel oozing and tissue removal creating dead space.
Purpose of the Study:
- To review the application of fibrin sealant (FS) in breast cancer surgery.
- To evaluate FS's efficacy in reducing postoperative serous drainage.
- To assess FS's role in improving hemostasis and tissue adherence post-dissection.
Main Methods:
- Review of existing research on fibrin sealant use in axillary lymph-node dissections.
- Analysis of studies focusing on FS for hemostasis and tissue adherence.
- Evaluation of data on the impact of FS on serous drainage and complication rates.
Main Results:
- Fibrin sealant demonstrates potential in managing oozing from small vessels.
- FS application may enhance tissue adherence, reducing dead space formation.
- Evidence suggests FS can decrease postoperative serous drainage.
Conclusions:
- Fibrin sealant is a promising adjunct in breast cancer surgery, specifically axillary dissections.
- Its use may mitigate common postoperative complications like seroma and hematoma.
- Further research can solidify FS's role in improving surgical outcomes.